Avalo Therapeutics: Abdakibart Delivers Breakout Phase 2 HS Data
AI Summary
Avalo Therapeutics has released promising data from a Phase 2 clinical trial for its new treatment, showing significant efficacy. This development may enhance future treatment options in the healthcare sector.